Waksal Harlan 4
4 · Lyra Therapeutics, Inc. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
Waksal Harlan
DirectorExecutive Chair
Transactions
- Award
Stock Option
2023-01-31+200,000→ 200,000 totalExercise: $2.85Exp: 2033-01-30→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2023.